Genomicare Biotechnology Co. Ltd., of Shanghai, said it completed its series A financing co-launched by Morningside Venture Capital, Apricot Tree Capital and Carebridge Holdings, for which China Renaissance Group provides exclusive financial consulting service. The company provides personalized and targeted clinical solutions and global resource matching service.